Jose Bolanos MD
  • Home
  • Portfolio Stuff
    • Portfolio
    • Investors
    • Company
  • Services
  • Contact Us
  • Blog
Select Page

Eli Lilly Wins U.S. Approval For Breast Cancer Drug

by Bill Berkrot | Oct 3, 2017 | BioPharma, Breast Cancer, Oncology

Source: Eli Lilly wins U.S. approval for breast cancer drug (Reuters) – The U.S. Food and Drug Administration said on Thursday it approved an Eli Lilly and Co drug to treat advanced breast cancer that has progressed following prior treatment. The drug,...
Next Entries »

Recent Posts

  • Cyber Risk Exchange Startup CyberGRX Raises $30 Million
  • U.S. Postal Service API Flaw Exposes Data of 60 Million Customers
  • US Employer-based health insurance premiums, deductibles rise | Healthcare Dive
  • Genomic Expression featured in Forbes – WON the EIC award
  • How 20 big-name US VC firms invest at Series A & B | PitchBook

Archives

  • November 2018
  • October 2018
  • September 2018
  • April 2018
  • March 2018
  • November 2017
  • October 2017
  • September 2017

Categories

  • AI & Machine Learning
  • BioPharma
  • Blockchain
  • Breast Cancer
  • Cryptocurrency
  • Cybersecurity
  • Encryption
  • Genomics
  • Hacked
  • Health Insurance
  • Hospitals
  • Identity
  • Investment Opportunity
  • Medical Devices
  • Mergers & Acquisitions
  • News
  • Oncology
  • Pharmaceutical
  • Robotics
  • Startups
  • Uncategorized
  • Venture Funding

USA:

21 Orinda Way #C-280
Orinda, CA 94562

 

 

Switzerland:

Tschopperlistrasse 7
4147 Aesch, BL

Translation


by Transposh - translation plugin for wordpress

Recent Blog Posts

  • Cyber Risk Exchange Startup CyberGRX Raises $30 Million
  • U.S. Postal Service API Flaw Exposes Data of 60 Million Customers
Copyright 2017 | Jose Bolanos MD
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok